Home › Trial NCT07493304
Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
- Trial IDNCT07493304
- StatusRecruiting
- PhasePhase 3
- Study typeInterventional
- SponsorRegeneron Pharmaceuticals
- Enrollment1600
- Start date2026-08-26
- ConditionsVenous Thromboembolism (VTE)
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.